FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2579551775> ?p ?o ?g. }

• W2579551775 endingPage "13651" @default.
• W2579551775 startingPage "13632" @default.
• W2579551775 abstract "We previously reported the role of cancer/testis antigen CAGE in the response to anti-cancer drugs. CAGE increased the expression of cyclinD1, and pGSK3βSer9, an inactive GSK3β, while decreasing the expression of phospho-cyclinD1Thr286. CAGE showed binding to GSK3β and the domain of CAGE (amino acids 231-300) necessary for binding to GSK3β and for the expression regulation of cyclinD1 was determined. 269GTGKT273 peptide, corresponding to the DEAD box helicase domain of CAGE, decreased the expression of cyclinD1 and pGSK3βSer9 while increasing the expression of phospho-cyclinD1Thr286. GTGKT peptide showed the binding to CAGE and prevented CAGE from binding to GSK3β. GTGKT peptide changed the localization of CAGE and inhibited the binding of CAGE to the promoter sequences of cyclin D1. GTGKT peptide enhanced the apoptotic effects of anti-cancer drugs and decreased the migration, invasion, angiogenic, tumorigenic and metastatic potential of anti-cancer drug-resistant cancer cells. We found that Lys272 of GTGKT peptide was necessary for conferring anti-cancer activity. Peptides corresponding to the DEAD box helicase domain of CAGE, such as AQTGTGKT, QTGTGKT and TGTGKT, also showed anti-cancer activity by preventing CAGE from binding to GSK3β. GTGKT peptide showed ex vivo tumor homing potential. Thus, peptides corresponding to the DEAD box helicase domain of CAGE can be developed as anti-cancer drugs in cancer patients expressing CAGE." @default.
• W2579551775 created "2017-01-26" @default.
• W2579551775 creator A5010288097 @default.
• W2579551775 creator A5048104934 @default.
• W2579551775 creator A5067207199 @default.
• W2579551775 creator A5067392576 @default.
• W2579551775 creator A5075257352 @default.
• W2579551775 creator A5077659343 @default.
• W2579551775 creator A5078485965 @default.
• W2579551775 creator A5080355049 @default.
• W2579551775 creator A5089920414 @default.
• W2579551775 date "2017-01-13" @default.
• W2579551775 modified "2023-09-30" @default.
• W2579551775 title "The pentapeptide Gly-Thr-Gly-Lys-Thr confers sensitivity to anti-cancer drugs by inhibition of CAGE binding to GSK3β and decreasing the expression of cyclinD1" @default.
• W2579551775 cites W1929964313 @default.
• W2579551775 cites W1972802011 @default.
• W2579551775 cites W1973364296 @default.
• W2579551775 cites W1983142511 @default.
• W2579551775 cites W1983199518 @default.
• W2579551775 cites W1988672563 @default.
• W2579551775 cites W1991782223 @default.
• W2579551775 cites W1992853617 @default.
• W2579551775 cites W2007860942 @default.
• W2579551775 cites W2015848047 @default.
• W2579551775 cites W2017793317 @default.
• W2579551775 cites W2021663476 @default.
• W2579551775 cites W2027350423 @default.
• W2579551775 cites W2033826636 @default.
• W2579551775 cites W2035754161 @default.
• W2579551775 cites W2037152390 @default.
• W2579551775 cites W2039554844 @default.
• W2579551775 cites W2042355239 @default.
• W2579551775 cites W2048667125 @default.
• W2579551775 cites W2049311433 @default.
• W2579551775 cites W2050980456 @default.
• W2579551775 cites W2053781426 @default.
• W2579551775 cites W2065395782 @default.
• W2579551775 cites W2065970920 @default.
• W2579551775 cites W2068862545 @default.
• W2579551775 cites W2074348836 @default.
• W2579551775 cites W2083538232 @default.
• W2579551775 cites W2091683380 @default.
• W2579551775 cites W2093868062 @default.
• W2579551775 cites W2096544051 @default.
• W2579551775 cites W2098415496 @default.
• W2579551775 cites W2106923555 @default.
• W2579551775 cites W2108958930 @default.
• W2579551775 cites W2109487755 @default.
• W2579551775 cites W2121272563 @default.
• W2579551775 cites W2122663740 @default.
• W2579551775 cites W2128436743 @default.
• W2579551775 cites W2136575012 @default.
• W2579551775 cites W2138081474 @default.
• W2579551775 cites W2140958498 @default.
• W2579551775 cites W2155477990 @default.
• W2579551775 cites W2164569756 @default.
• W2579551775 cites W2398951825 @default.
• W2579551775 cites W2403344917 @default.
• W2579551775 doi "https://doi.org/10.18632/oncotarget.14621" @default.
• W2579551775 hasPubMedCentralId "https://www.ncbi.nlm.nih.gov/pmc/articles/5355126" @default.
• W2579551775 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/28099142" @default.
• W2579551775 hasPublicationYear "2017" @default.
• W2579551775 type Work @default.
• W2579551775 sameAs 2579551775 @default.
• W2579551775 citedByCount "15" @default.
• W2579551775 countsByYear W25795517752017 @default.
• W2579551775 countsByYear W25795517752018 @default.
• W2579551775 countsByYear W25795517752019 @default.
• W2579551775 countsByYear W25795517752020 @default.
• W2579551775 countsByYear W25795517752021 @default.
• W2579551775 countsByYear W25795517752022 @default.
• W2579551775 countsByYear W25795517752023 @default.
• W2579551775 crossrefType "journal-article" @default.
• W2579551775 hasAuthorship W2579551775A5010288097 @default.
• W2579551775 hasAuthorship W2579551775A5048104934 @default.
• W2579551775 hasAuthorship W2579551775A5067207199 @default.
• W2579551775 hasAuthorship W2579551775A5067392576 @default.
• W2579551775 hasAuthorship W2579551775A5075257352 @default.
• W2579551775 hasAuthorship W2579551775A5077659343 @default.
• W2579551775 hasAuthorship W2579551775A5078485965 @default.
• W2579551775 hasAuthorship W2579551775A5080355049 @default.
• W2579551775 hasAuthorship W2579551775A5089920414 @default.
• W2579551775 hasBestOaLocation W25795517751 @default.
• W2579551775 hasConcept C114614502 @default.
• W2579551775 hasConcept C121608353 @default.
• W2579551775 hasConcept C153911025 @default.
• W2579551775 hasConcept C160272327 @default.
• W2579551775 hasConcept C185592680 @default.
• W2579551775 hasConcept C2779281246 @default.
• W2579551775 hasConcept C33923547 @default.
• W2579551775 hasConcept C45197812 @default.
• W2579551775 hasConcept C502942594 @default.
• W2579551775 hasConcept C54355233 @default.
• W2579551775 hasConcept C55493867 @default.
• W2579551775 hasConcept C86803240 @default.
• W2579551775 hasConcept C96232424 @default.
• W2579551775 hasConceptScore W2579551775C114614502 @default.
• W2579551775 hasConceptScore W2579551775C121608353 @default.

• next